glutathione and disulfiram together in liver diseases: a double-edged sword | Naunyn-Schmiedeberg's Archives of Pharmacology FDA-approved disulfiram inhibits the NLRP3
Description
doi: 10.1111/j.1365-2230.2011.04019.x
Weve all had that experience of a person being on an anti-coagulant, they had to go to surgery, and we have to reverse quickly
J Educ Chang Transl Med
The limitations of our study include the fact that the data were obtained from a relatively small number of patients (especially adults) in three different trials in which Norditropin was included only as a one-dose-level control group
A., Pradier, L., Wood, N
